Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association

Lower extremity peripheral artery disease (PAD) affects >230 million adults worldwide and is associated with increased risk of various adverse clinical outcomes (other cardiovascular diseases such as coronary heart disease and stroke and leg outcomes such as amputation). The statement also lists key gaps in research, clinical practice, and implementation related to PAD.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 Despite its prevalence and clinical importance, PAD has been historically underappreciated by health care professionals and patients.
• 2 This underappreciation seems multifactorial (eg, limited availability of the first-line diagnostic test, the ankle-brachial index, in clinics; incorrect perceptions that a leg vascular disease is not fatal and that the diagnosis of PAD would not necessarily change clinical practice).
• 3 In the past several years, a body of evidence has indicated that these perceptions are incorrect.

These innovations can translate to real-world improvements in technology, infrastructure, and everyday tools.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: